Drug Profile
Stromal vascular fraction - osteoarthritis - Translational Biosciences
Alternative Names: SVF - osteoarthritis - Translational BiosciencesLatest Information Update: 27 Apr 2023
Price :
$50
*
At a glance
- Originator Translational Biosciences
- Class Antirheumatics; Growth factors; Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Osteoarthritis
Most Recent Events
- 27 Apr 2023 Discontinued - Preclinical for Osteoarthritis in Panama (Intra-articular)
- 28 Nov 2019 No recent reports of development identified for preclinical development in Osteoarthritis in Panama (Intra-articular, Injection)
- 26 Oct 2015 Preclinical trials in Osteoarthritis in Panama (Intra-articular)